RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31

RadNet, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$69.27+0.47 (+0.68%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2011 to 2025

–

3.0%−0.3 pts over 5 years

-0.9%+0.5 pts over 5 years

Per year	1 year	3 years	5 years	10 years	Five-year pace
Revenue	+11.5%	+12.6%	+13.7%	+9.7%
Operating income	-40.7%	+10.2%	+11.7%	+4.7%

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	16.3%	-9.4%	-1.9%
Return on assets	1.6%	-0.9%	-0.5%
Current ratio	1.40	0.68	1.76
Debt to equity	12.22	3.94	1.00
Net debt to EBITDA	5.86×	4.50×	1.51×
Interest coverage	0.9×	0.8×	0.9×
Capex to revenue	6.7%	–	–
Diluted shares	47M	51M	75M

Return on equity split into margin, efficiency and leverage

Net margin-0.9%

Asset turnover0.58×

Equity multiplier3.54×

Return on equity, FY2025-1.9%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	-0.9%	0.58×	3.54×	-1.9%
FY2024	0.2%	0.61×	3.90×	0.4%
FY2023	0.2%	0.63×	5.32×	0.6%
FY2022	0.7%	0.64×	7.99×	3.8%
FY2021	1.9%	0.68×	9.74×	12.5%
FY2020	-1.4%	0.62×	10.82×	-9.4%
FY2019	1.3%	0.84×	9.88×	10.6%
FY2018	3.3%	0.99×	10.48×	34.2%
FY2017	0.0%	1.07×	15.13×	0.1%
FY2016	0.8%	2.00×	10.00×	16.3%

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RDNT.

Revenue growth18.9% · median 13.6%

Operating margin3.1% · median 1.7%

Net margin-0.9% · median 1.0%

Advertisement
300 × 250